跳至主要内容
临床试验/NCT02366481
NCT02366481Unknown不适用

Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes

Augusta University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
2
主要终点
Change in insulin sensitivity

研究概览

简要总结

Given that glutamate carboxylation or decarboxylation is key to the metabolic role of osteocalcin (at least in mouse models) and that carboxylation is vitamin K dependent, it is critical to isolate the effect of vitamin K manipulation on carboxylation of osteocalcin and its subsequent effect on glucose metabolism in clinical trials. The purpose of this randomized, double-blind, placebo-controlled clinical trial in adults is to determine whether eight weeks of daily supplementation with vitamin K2 (menaquinone-7) can improve markers in blood associated with diabetes risk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults between 18 and 65 years old
  • Subject understands the study protocol and agrees to comply with it
  • Informed Consent Form signed by the subject

排除标准

  • Subjects using vitamin supplements containing vitamin k
  • Subjects with (a history of) metabolic or gastrointestinal diseases including hepatic disorders
  • Subjects presenting chronic degenerative and/or inflammatory diseases
  • Subjects receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (salicylates, antibiotics)
  • Subjects receiving corticosteroid treatment
  • Subjects using oral anticoagulants
  • Subjects with a history of soy allergy
  • Subjects who have participated in a clinical study more recently than one month before the current study

结局指标

主要结局

Change in insulin sensitivity

时间窗: Change from baseline in insulin sensitivity at 8 weeks

Insulin sensitivity will be calculated from plasma insulin and glucose concentrations measured during a 2-hour oral glucose tolerance test by using the oral glucose minimal model.

Change in beta-cell function

时间窗: Change from baseline in beta-cell function at 8 weeks

Beta-cell function, as assessed by dynamic beta-cell responsitivity, will be calculated from plasma glucose and C-peptide concentrations measured during a 2-hour oral glucose tolerance test by using the oral C-peptide minimal model.

次要结局

  • Change in arterial stiffness (PWV)(Change from baseline in arterial stiffness at 8 weeks)
  • Change in prothrombin time (PT)(Change from baseline in PT at 8 weeks)
  • Change in activated partial thromboplastin time (aPTT)(Change from baseline in aPTT at 8 weeks)
  • Change in endothelial function (FMD)(Change from baseline in endothelial function at 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Norman Pollock

Associate Professor, Department of Medicine

Augusta University

研究点 (2)

Loading locations...

相似试验